ADHD, Gut Problems and Synbiotic
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-64
SponsorSuper Synbiotics AB
About this trial
The scope of this study is to evaluate the impact of a synbiotic product (a combination of probiotic bacteria and prebiotics) on symptoms reported by participants with ADHD. The main focus is to study the efficacy of the synbiotic product as compared to a placebo in improving emotion regulation and gut-health associated symptoms in adults with ADHD.
Eligibility criteria
Qualifiers
ADHD-diagnosis
Self-described gastrointestinal problems
Has not previously consumed Synbiotics
Be prepared to avoid supplements with lactic acid bacteria, calcium and vitamin B6, B9, and B12, starting from washout
Disqualifiers
Has consumed antibiotics within the previous 6 weeks
Has a serious disease that requires treatment and/or leads to a weakened immune system
Trial design
Treatments tested in this trial
- Synbiotic Cap Gut-Brain
- Placebo
Treatment groups
174 Participants
are divided into 2 treatment groupsLocations
Sponsors and collaborators
Source ClinicalTrials.gov